{
    "clinical_study": {
        "@rank": "132739", 
        "arm_group": [
            {
                "arm_group_label": "Bifidobacterium lactis plus inulin", 
                "arm_group_type": "Active Comparator", 
                "description": "Bifidobacterium lactis plus inulin"
            }, 
            {
                "arm_group_label": "maltodextrin", 
                "arm_group_type": "Placebo Comparator", 
                "description": "maltodextrin"
            }
        ], 
        "brief_summary": {
            "textblock": "Infants with congenital heart disease have more frequent infections and exposures to\n      antibiotics than healthy infants. The investigators hypothesized that synbiotics may reduce\n      the rate of sepsis and necrotizing enterocolitis in infants with CHD"
        }, 
        "brief_title": "Synbiotics in Infants With Cyanotic Congenital Heart Disease", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Congenital Heart Disease", 
        "condition_browse": {
            "mesh_term": [
                "Heart Diseases", 
                "Heart Defects, Congenital"
            ]
        }, 
        "detailed_description": {
            "textblock": "Infants with congenital heart disease have more frequent infections and exposures to\n      antibiotics than healthy infants. Probiotics may prevent pathogen colonization in infants\n      with CHD. Therefore, the investigators hypothesized that synbiotics may reduce the rate of\n      sepsis and necrotizing enterocolitis in infants with CHD"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Cyanotic congenital heart disease\n\n          -  infants >35 weeks of gestational age\n\n          -  Born at or transferred to Sami Ulus CH\n\n        Exclusion Criteria:\n\n          -  Congenital anomalies of the intestinal tract"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "3 Months", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01810978", 
            "org_study_id": "128/01.10.2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "maltodextrin", 
                "description": "5 billion unit Bifidobacterium lactis plus 900 mg inulin per day will be given", 
                "intervention_name": "Bifidobacterium lactis plus inulin", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Bifidobacterium lactis plus inulin", 
                "description": "same amount of maltodextrin per day will be given as placebo", 
                "intervention_name": "Maltodextrin", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "congenital heart disease, probiotic, prebiotic", 
        "lastchanged_date": "May 7, 2013", 
        "link": {
            "description": "http://www.ncbi.nlm.nih.gov/pubmed/21468216", 
            "url": "http://www.ncbi.nlm.nih.gov/pubmed/21468216"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Ankara", 
                    "country": "Turkey", 
                    "zip": "06120"
                }, 
                "name": "Sami Ulus CH"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy of Synbiotics in Infants With Cyanotic Congenital Heart Disease", 
        "overall_official": {
            "affiliation": "MD", 
            "last_name": "Banu Ayd\u0131n, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Sepsis", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01810978"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Dr. Sami Ulus Children's Hospital", 
            "investigator_full_name": "Dilek Dilli", 
            "investigator_title": "Assoc Prof", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "21468216", 
            "citation": "Ellis CL, Rutledge JC, Underwood MA. Intestinal microbiota and blue baby syndrome: probiotic therapy for term neonates with cyanotic congenital heart disease. Gut Microbes. 2010 Nov-Dec;1(6):359-66. doi: 10.4161/gmic.1.6.14077. Review."
        }, 
        "secondary_outcome": {
            "measure": "Necrotizing enterocolitis", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "source": "Dr. Sami Ulus Children's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Sami Ulus Children's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}